Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124481046 | 12448104 | 6 | F | 20160526 | 20160921 | 20160608 | 20160928 | EXP | CN-ASTELLAS-2016JP008743 | ASTELLAS | 82.78 | YR | M | Y | 57.00000 | KG | 20160928 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124481046 | 12448104 | 1 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | 90240 | MG | D | 0 | 160 | MG | FORMULATION UNKNOWN | QD | ||||
| 124481046 | 12448104 | 2 | PS | Enzalutamide | ENZALUTAMIDE | 1 | Oral | 640 | MG | D | 203415 | 160 | MG | FORMULATION UNKNOWN | QD | ||||
| 124481046 | 12448104 | 3 | C | LEUPROLIDE /00726901/ | 2 | Intramuscular | 2809 | MG | D | U | 0 | 3.75 | MG | INJECTION | /month | ||||
| 124481046 | 12448104 | 4 | C | YIXUESHENG JIAO NANG | 2 | Oral | 0.25 G, ONCE DAILY | 122 | G | D | U | 0 | .25 | G | PER ORAL NOS | QD | |||
| 124481046 | 12448104 | 5 | C | YIXUESHENG JIAO NANG | 2 | Oral | 122 | G | D | U | 0 | 3 | G | PER ORAL NOS | QD | ||||
| 124481046 | 12448104 | 6 | C | PAMIDRONATE DISODIUM. | PAMIDRONATE DISODIUM | 1 | Intravenous (not otherwise specified) | D | U | 0 | 60 | MG | INJECTION | QD | |||||
| 124481046 | 12448104 | 7 | C | VITAMIN B2 /00154901/ | 2 | Oral | D | U | 0 | 5 | MG | PER ORAL NOS | QD | ||||||
| 124481046 | 12448104 | 8 | C | VITAMIN AD | PETROLATUM | 1 | Oral | D | U | 0 | 10000 | IU | PER ORAL NOS | QD | |||||
| 124481046 | 12448104 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | D | U | 0 | 100 | MG | PER ORAL NOS | QD | |||||
| 124481046 | 12448104 | 10 | C | SHU JIN JIE LI JIAONANG | 2 | Oral | 375 | G | D | U | 0 | 2.7 | G | PER ORAL NOS | QD | ||||
| 124481046 | 12448104 | 11 | C | LIAN HUA QING | 2 | Oral | 1.75 | G | D | U | 0 | 1.75 | G | CAPSULE | QD | ||||
| 124481046 | 12448104 | 12 | C | AMINO ACID | AMINO ACIDS | 1 | Intravenous (not otherwise specified) | UNKNOWN DOSE | D | U | 0 | INJECTION | |||||||
| 124481046 | 12448104 | 13 | C | RED BLOOD CELLS | HUMAN RED BLOOD CELL | 1 | Intravenous (not otherwise specified) | UNKNOWN DOSE | D | U | 0 | INJECTION | |||||||
| 124481046 | 12448104 | 14 | C | CARBAZOCHROME SODIUM SULFONATE | CARBAZOCHROME SODIUM SULFONATE | 1 | Intravenous (not otherwise specified) | UNKNOWN DOSE | D | U | 0 | INJECTION | |||||||
| 124481046 | 12448104 | 15 | C | MEGESTROL ACETATE. | MEGESTROL ACETATE | 1 | Oral | UNKNOWN DOSE | D | U | 0 | TABLET | |||||||
| 124481046 | 12448104 | 16 | C | IRON POLYSACCHARIDE COMPLEX | 2 | Oral | UNKNOWN DOSE | D | U | 0 | CAPSULE | ||||||||
| 124481046 | 12448104 | 17 | C | MINO SODIUM | 2 | Intravenous (not otherwise specified) | UNKNOWN DOSE | D | U | 0 | INJECTION | ||||||||
| 124481046 | 12448104 | 18 | C | RECOMBINANT HUMAN?LNTERLEUKIN-11 | 2 | Intramuscular | UNKNOWN DOSE | D | U | 0 | INJECTION | ||||||||
| 124481046 | 12448104 | 19 | C | RAY BELLA SODIUM | 2 | Oral | UNKNOWN DOSE | D | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124481046 | 12448104 | 1 | Hormone-refractory prostate cancer |
| 124481046 | 12448104 | 2 | Hormone-refractory prostate cancer |
| 124481046 | 12448104 | 3 | Prostate cancer |
| 124481046 | 12448104 | 4 | Anaemia |
| 124481046 | 12448104 | 6 | Metastases to bone |
| 124481046 | 12448104 | 7 | Prophylaxis |
| 124481046 | 12448104 | 8 | Mineral supplementation |
| 124481046 | 12448104 | 9 | Mineral supplementation |
| 124481046 | 12448104 | 10 | Muscular weakness |
| 124481046 | 12448104 | 11 | Pyrexia |
| 124481046 | 12448104 | 12 | Anaemia |
| 124481046 | 12448104 | 13 | Anaemia |
| 124481046 | 12448104 | 14 | Haemorrhage prophylaxis |
| 124481046 | 12448104 | 15 | Prostate cancer |
| 124481046 | 12448104 | 16 | Anaemia |
| 124481046 | 12448104 | 17 | Emphysema |
| 124481046 | 12448104 | 18 | Platelet count decreased |
| 124481046 | 12448104 | 19 | Gastritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124481046 | 12448104 | HO |
| 124481046 | 12448104 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124481046 | 12448104 | Lung infection | |
| 124481046 | 12448104 | Nausea | |
| 124481046 | 12448104 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124481046 | 12448104 | 1 | 20141106 | 20160522 | 0 | |
| 124481046 | 12448104 | 2 | 20160523 | 20160527 | 0 | |
| 124481046 | 12448104 | 3 | 20140529 | 0 | ||
| 124481046 | 12448104 | 4 | 20150216 | 0 | ||
| 124481046 | 12448104 | 5 | 20150414 | 0 | ||
| 124481046 | 12448104 | 6 | 20140904 | 0 | ||
| 124481046 | 12448104 | 7 | 201409 | 0 | ||
| 124481046 | 12448104 | 8 | 2007 | 0 | ||
| 124481046 | 12448104 | 9 | 201409 | 0 | ||
| 124481046 | 12448104 | 10 | 20160129 | 0 | ||
| 124481046 | 12448104 | 11 | 20160526 | 20160526 | 0 | |
| 124481046 | 12448104 | 12 | 20160527 | 201606 | 0 | |
| 124481046 | 12448104 | 13 | 20160527 | 201606 | 0 | |
| 124481046 | 12448104 | 14 | 20160527 | 201606 | 0 | |
| 124481046 | 12448104 | 15 | 201606 | 201606 | 0 | |
| 124481046 | 12448104 | 16 | 201605 | 201606 | 0 | |
| 124481046 | 12448104 | 17 | 20160527 | 201606 | 0 | |
| 124481046 | 12448104 | 18 | 20160527 | 201606 | 0 | |
| 124481046 | 12448104 | 19 | 201606 | 201606 | 0 |